肥胖患者腹手术后血清尿酸水平的变化:一项观察性研究
Daniel W Mills1, Dylan M Woolley1, Basil J Ammori2,3,4
1General (Internal) Medicine, Salford Royal Hospital, Northern Care Alliance NHS Foundation Trust, Salford, UK.
Obesity surgery
|March 26, 2024
概括
腹腔外科手术在两年内显著降低血清尿酸水平. 这种减肥干预可以降低痛风的风险和需要药物的需要.
科学领域:
- 代谢手术 代谢手术
- 腎臟病學 (nephrology) 是一種醫學專業.
- 肥胖医学 肥胖医学
背景情况:
- 肥胖是高尿血和痛风的已知危险因素.
- 减肥策略可以有效降低血清尿酸盐水平.
- 减肥手术是一种减肥干预,具有潜在的代谢益处.
研究的目的:
- 研究减肥手术对血清尿酸盐水平的长期影响.
- 评估减肥手术在减少高尿血的疗效.
- 为了评估减肥手术对不同患者人口统计学的影响.
主要方法:
- 对283名接受减肥手术的患者进行了回顾性观察性研究.
- 手术后2年的随访期. 手术后2年的随访期.
- 在基线,12个月和24个月时分析血清尿酸盐水平.
主要成果:
- 血清尿酸的平均水平从基线时的0.343 mmol/L显著降低到12个月后的0.296 mmol/L (p < 0.001) 和24个月后的0.286 mmol/L (p < 0.001).
- 在男性和女性以及患有或没有糖尿病的患者中观察到的减少.
- 患有基线超尿血症的患者在4个月后显示水平降低.
结论:
- 腹腔外科手术在手术后12个月和24个月有效降低血清尿酸水平.
- 这种减少可能会降低痛风的发病率.
- 有可能减少对预防性痛风药物的需求.
相关概念视频
Drug Dosing: Obese Patients
In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution
Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion
Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...
Urinary Tract Calculi IV: Nutrition Therapy and Prevention
Management of renal calculi focuses on effective strategies like tailored nutrition and hydration therapy. Adjusting diet and fluid intake reduces stone formation and recurrence, making these interventions simple yet powerful in kidney stone prevention and management.Understanding Kidney StonesKidney stones form when calcium, oxalate, uric acid, and cystine concentrate and crystallize in urine. Factors contributing to their formation include genetic predisposition, certain medical conditions,...
Urinary Tract Calculi VI: Surgical Management
Procedures for Kidney StonesMedical intervention is necessary when kidney stones or renal calculi are too large to pass spontaneously (typically greater than 5 millimeters) when stones are accompanied by symptomatic infection (such as fever or pyelonephritis), when they impair kidney function, or when they cause persistent symptoms like severe pain, nausea, or urinary retention. Additionally, patients with only one kidney or those who cannot be treated with medical management also require...
Serum Studies: Renal Function Tests
Renal function tests are crucial for assessing kidney health, monitoring disease progression, and evaluating the kidneys' efficiency in waste elimination, fluid balance, and electrolyte regulation. These tests offer critical insights into kidney function, even though routine measurements may appear normal until there is a significant decline in the glomerular filtration rate or GFR. Typically, signs of kidney impairment only become evident when the GFR falls to about 50% of its normal level.


